Magnera AI Stock Analysis
Magnera (MAGN) AI Stock Analysis
Magnera
(BX Swiss:MAGN)
No summary available
Magnera Business Overview & Revenue Model
Company Description
Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care. The company offers personal care and consumer solution pro...
Magnera Earnings Call Summary
The call was broadly positive, supported by year-over-year earnings growth, strong free cash flow, debt reduction, synergy realization, operational improvements, product innovation and fiscal 2027 EBITDA growth guidance of approximately 6%. However, management also highlighted softer volumes, European and Chinese macroeconomic headwinds, inflation and energy costs, inventory volatility, an impairment charge and leverage that remains above the 3x target. The achievements and outlook significantly outweighed the stated challenges.
Q4-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For fiscal 2027, Magnera is guiding to an expected EBITDA earnings improvement of 6%, with comparable EBITDA at the midpoint of $400 million expected to grow approximately 6% year-over-year on a constant currency basis; volume assumptions are essentially low single-digit growth in the Americas, slightly low single-digit negative or flattish in Europe, with the midpoint being flat from a volume standpoint, the higher end of the EBITDA range being plus 2% on volume and the lower end being 2% less. Free cash flow is expected to range from $110 million to $130 million and be back half weighted, with approximately $85 million of capital investments; at the midpoint, about $120 million of free cash flow is intended for debt reduction, with leverage at roughly 3.6x as the company marches towards its 3x target, alongside $125 million of cash interest, $50 million of tax integration, $20 million of additional Project CORE items, and cash taxes of 10% to 11% as a percentage of EBITDA. Rollover benefits are roughly $20 million from 2026 actions versus roughly $45 million of benefit in 2026, Europe is roughly 70% hedged for 2027 energy, and extra shipping days are expected to provide around $5 million or $6 million of benefit.
Magnera Risk Analysis
Magnera disclosed 32 risk factors in its most recent earnings report. Magnera reported the most risks in the "Macro & Political" category.
Latest Risks Added
0 New RisksMagnera Peers Comparison
Overall Rating
REYN75Outperform
PG72Outperform
KMB69Neutral
CLX64Neutral
EPC51Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | $5.17B | 15.79 | 14.15% | 3.78% | 2.45% | 6.45% | |
| 72Outperform | $389.04B | 25.05 | 29.55% | 2.55% | 3.52% | -3.74% | |
| 69Neutral | $64.59B | 10.71 | 162.62% | 4.79% | -8.38% | 67.47% | |
| 64Neutral | $12.71B | 18.84 | -1920.57% | 4.76% | 6.28% | -13.15% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 51Neutral | $1.27B | -25.65 | -3.53% | 2.11% | -10.21% | -310.40% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CLX | Clorox Company | 104.73 | 4.18 | 4.16% | |
| KMB | Kimberly Clark | 106.38 | 6.46 | 6.47% | |
| PG | Procter & Gamble Company | 169.37 | 26.53 | 18.58% | |
| EPC | Edgewell Personal Care Co | 28.47 | 11.50 | 67.76% | |
| REYN | Reynolds Consumer Products Inc | 24.32 | 0.93 | 3.99% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
